Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade.
Publication date: Apr 17, 2026 Patients with resected, high-risk melanoma receive adjuvant immune checkpoint blockade ...